Bioharvest issues shareholder letter and provides corporate update

Vancouver, british columbia and rehovot, israel--(newsfile corp. - january 8, 2025) - bioharvest sciences inc. , (nasdaq: bhst) (cse: bhsc) (fse: 8mv0) ("bioharvest" or "the company"), a company pioneering its patented botanical synthesis technology process, today issued a letter to shareholder partners from chief executive officer, ilan sobel. dear fellow shareholders, 2024 can be summarized as a year of transformation and growth for bioharvest, where we introduced our new cdmo services division - anchored by a partnership with a tier-1 food ingredients producer, tate & lyle.
BHST Ratings Summary
BHST Quant Ranking